Granzyme A (GzmA) is a serine protease (trypsinlike specificity) produced in cytotoxic lymphocytes. This enzyme is believed to enter virus-infected cells and growing tumors and induce apoptosis, but the roles of GzmA expressed in lymphocytes scattered through the epithelial layer of the normal small intestine are unknown. In the present study, recombinant rat GzmA (rGzmA) was found to cause morphological changes and detachment of a non-transformed rat small-intestinal epithelial cell line IEC-6, although the rGzmA-treated cells detached as aggregates with no changes characteristic of apoptosis. rGzmA-induced deformation and detachment occurred in IEC-6 cells plated with collagen type IV and fibronectin, but not in those plated with laminin. These findings suggest that GzmA in the normal small intestine participates in the reduction of adhesion between epithelial cells and basement membranes, through its ability to cleave extracellular matrix components.
Key words: cell adhesion; exfoliation; extracellular matrix; granzyme A; small-intestinal epithelial cells
The cells of the epithelial lining of the small intestine (hereafter intestinal epithelial cells, IECs) play important roles in both nutrient absorption and barrier functions. IECs are generated by stem cells at the crypt base and migrate towards the lumen, during which time many differentiate into absorptive cells called enterocytes. Closer to the villus tip, the expression of brush border enzymes in enterocytes increases while the adhesiveness of the cells to the substratum (basement membrane) decreases. [1] [2] [3] At the villus tip, their short life cycle is terminated because the cells lose cell-cell and cell-basement membrane adhesion and are shed into the lumen in the process of apoptosis. 3, 4) Although various proteolytic events might be involved in the reduction of cell adhesions, details of the underlying mechanisms are largely unknown. Granzyme A (GzmA) is a serine protease with trypsin-like specificity found in large granules of activated cytotoxic T lymphocytes and natural killer cells located in the peripheral blood and lymphoid tissues. 5, 6) GzmA is believed to function by entering abnormal cells (virus-infected cells and growing tumors) via pores formed by perforin, which is also contained in activated immune cells, and participating in the apoptosis of abnormal cells. 5, 6) Of interest is the finding that GzmA is expressed in immune cells termed intraepithelial lymphocytes (IELs) scattered through the epithelial layer of the small intestine. 7, 8) Normally, the small intestine contains a very large number of IELs, estimated to be approximately 1 IEL for every 6 to 10 IECs. The majority of small-intestinal IELs are thought to be resting (non-activated) lymphocytes, because they do not express proteins associated with cytolytic function such as perforin. 7) Nevertheless, approximately 30% of the IELs of the normal human small intestine are GzmA-positive. 7) More importantly, GzmA-positive IELs frequently appear at the upper ends of villi, where enterocytes mature or are shed into the lumen. 7, 8) Furthermore, in vitro studies have shown that GzmA has the ability to cleave extracellular matrix (ECM) components such as collagen type IV and fibronectin, which constitute the basement membranes of epithelial cells, including IECs. 9, 10) These findings led us to hypothesize that GzmA expressed in the IELs of the normal small intestine participates in the reduction of adhesion between IECs and the basement membranes through cleavage of ECM components, thereby contributing to the maturation and/or exfoliation of the cells.
The purpose of the present study was to obtain cell biological evidence that GzmA reduces the adhesion of y To whom correspondence should be addressed. Fax: +81-75-753-6264; E-mail: tkmone@kais.kyoto-u.ac.jp Abbreviations: ALP, alkaline phosphatase; BLT, N--benzyloxy-L-lysine thiobenzyl ester; DMEM, Dulbecco's modified Eagle medium; DTNB, 5,5 0 -dithiobis-(2-nitrobenzoic acid); ECM, extracellular matrix; FITC, fluorescein isothiocyanate; GzmA, granzyme A; IECs, intestinal epithelial cells; IELs, intraepithelial lymphocytes; PBS, phosphate buffered saline; p-NPP, para-nitrophenyl phosphate; PSTI, pancreatic secretory trypsin inhibitor; RA, retinoic acid; rGzmA, recombinant rat GzmA; rPSTI, recombinant rat PSTI; SFM, serum-free DMEM supplemented with 4 mg/l insulin and 0.1% BSA; STS, staurosporine; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling IECs. For this, we conducted an in vitro experiment using IEC-6, a non-transformed rat small-intestinal epithelial cell line. This cell line has been used in numerous studies to clarify the mechanisms of various events in IECs, including proliferation, differentiation, and death. [11] [12] [13] [14] [15] In the present study, we found that a recombinant rat GzmA (rGzmA) caused morphological changes and detachment of the cell line. This is the first cell biological evidence that GzmA can reduce the adhesion of IECs.
Materials and Methods
Materials. BSA (protease-free), collagen type IV (collagen IV) (human placenta), 5,5 0 -dithiobis-(2-nitrobenzoic acid) (DTNB), fibronectin (human plasma), insulin (cell culture tested), laminin (Engelbreth-HolmSwarm murine sarcoma basement membrane), N--benzyloxy-L-lysine thiobenzyl ester (BLT), para-nitrophenyl phosphate (p-NPP) (di-sodium salt), phalloidin labeled with fluorescein isothiocyanate (FITC), retinoic acid (RA) (all-trans-RA), thrombin (bovine plasma), and trypsin (bovine pancreas, type III) were purchased from Sigma (St. Louis, MO). Dulbecco's modified Eagle medium (DMEM) (high glucose, supplemented with L-glutamine), a penicillin and streptomycin mixture, and fetal bovine serum were from Invitrogen (Carlsbad, CA). Chondroitin sulfate A was from Nacalai Tesque (Kyoto, Japan). Heparin and staurosporine (STS) were from Wako Pure Chemicals (Tokyo). All other chemicals were of analytical grade.
Cell culture. IEC-6 cells were obtained from the American Type Culture Collection (Rockville, MD) at passage 13, and were maintained in DMEM supplemented with 5% fetal bovine serum, 4 mg/l insulin, 100 IU/ml penicillin, and 100 IU/ml streptomycin at 37 C in 5% CO 2 , as described previously.
16)
Preparation of recombinant proteins. Production of rGzmA and a recombinant rat pancreatic secretory trypsin inhibitor (rPSTI) in Pichia pastoris and their purification by means of single-step chromatography using Ni 2þ -charged resin (HisLinkÔ resin, Promega, Madison, WI) were performed as described previously, 8, 17, 18) except that a buffer (25 mM HEPES, pH 8.0, containing 145 mM NaCl and 0.1% BSA) was used in purification. In order to obtain the active form, purified rGzmA was incubated with 2.0 units/ml of recombinant enterokinase (Novagen, Madison, WI) for 18 h at 22 C. Active rGzmA was repurified using Ni 2þ -charged resin. Finally, activated rGzmA and purified rPSTI were subjected to gel filtration in serum-free DMEM supplemented with 4 mg/l insulin and 0.1% BSA (SFM) using a NAP-10 column (GE Healthcare Japan, Tokyo). Active-site titration for rGzmA was conducted as follows: 5 ml of gel filtrate containing rGzmA was incubated in a well of a 96-well plate (Asahi Techno Glass, Tokyo) with 200 mM BLT (substrate) and 500 mM DTNB (color developer) in a HEPES buffer (25 mM HEPES, pH 8.0, 145 mM NaCl, and 0.1% Triton X-100) at 22 C in a final volume of 200 ml. Color development was measured at 405 nm at 30 s intervals for 60 min using a microplate reader (Multiskan MS; Labsystems, Helsinki, Finland). The nonenzymic rate of increase in absorbance was subtracted from the enzyme-catalyzed rate. For durations up to 60 min, 0.2 pmol rGzmA (the amount predetermined by SDS-PAGE followed by silver staining using bovine trypsin as a standard) caused a linear increase in the absorbance value (0.40 per 60 min).
Active-site titration for rPSTI was conducted as follows: 5 ml gel filtrate containing rPSTI was mixed with 95 ml of HEPES buffer containing 0.2 pmol rGzmA and 1 mM DTNB, and the mixture was incubated for 30 min at 22 C. The reaction was initiated by the addition of 100 ml of 400 mM BLT. Inclusion of 400 pmol rPSTI (the amount predetermined as described above) decreased the color development catalyzed by rGzmA to 0.36 per 60 min. After titration, the remainder of each gel filtrate was diluted with SFM, sterile filtered, and used in experiments.
Treatment of rGzmA, light microscopic observation, and cell detachment assay. Trypsinized IEC-6 cells were seeded into 48-well plates (Asahi Techno Glass) at a density of 5 Â 10 3 cells/well and incubated for 24 h. After incubation, the cells (90% confluent) were washed 3 times with SFM (0 h), exposed to SFM, SFM containing various concentrations of rGzmA (1-300 nM), SFM containing 100 nM trypsin, or SFM containing 300 nM thrombin, and incubated for an additional 48 h. Cell morphology was examined under a light microscope at 6, 12, 24, and 48 h. After microscopic observation, cell detachment was assessed as follows: Conditioned media were harvested. Cells that remained attached were washed twice with phosphate buffered saline (PBS; 8 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 136 mM NaCl, 2.7 mM KCl, pH 7.4), and then lysed with 50 ml of 0.5 N NaOH solution. Detached cells included in the conditioned media were precipitated by centrifugation at 5,000 g for 2 s at 22 C, washed twice with PBS, and lysed with 50 ml of 0.5 N NaOH. These lysates were centrifuged at 10,000 g for 10 min at 4 C to remove insoluble debris. The protein contents in the resulting supernatants were determined using a BCA protein assay kit (Pierce Chemical, Rockford, IL) with BSA as the standard. Cell detachment was expressed as the percentage of protein contents obtained from the detached cells in the total protein contents (contents from the detached cells and from cells that remained attached).
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and determination of caspase-3 activity. IEC-6 cells (90% confluent) were incubated for 24 h at 37 C with SFM, SFM containing 300 nM rGzmA, or SFM containing 100 nM STS. For TUNEL staining, cells that remained attached were washed twice with PBS and fixed with PBS containing 4% formaldehyde. TUNEL staining was performed using an In situ Apoptosis Detection kit including dUTP conjugated with FITC (Takara Bio, Ohtsu, Shiga, Japan) according to the manufacturer's instructions. Fluorescence images were acquired by confocal fluorescence microscopy (Fluoview FV300, Olympus, Tokyo).
For determination of caspase-3 activity, conditioned medium that included detached cells was harvested and the cells that remained attached were harvested by scraping and washing with PBS. The conditioned media and the cell suspension were pooled and precipitated by centrifugation at 5,000 g for 2 s at 22 C. After several washes with PBS, cells were extracted with 50 ml of an extraction buffer contained in the Caspase-3 Colorimetric Activity Assay Kit (Chemicon International, Temecula, CA). Caspase-3 activity in the extracts was determined using the kit as follows: Eighteen microliters of the cell extract was mixed with 2 ml of extraction buffer or a buffer containing 100 mM acetyl-L-Asp-LGlu-L-Val-L-Asp-1-aldehyde (a synthetic inhibitor for caspase-3), and the mixture was incubated for 10 min at 22 C. After incubation, 80 ml of an assay buffer (included in the kit) containing 375 mM acetyl-L-Asp-LGlu-L-Val-L-Asp-p-nitroanilide (a synthetic substrate for caspase-3) was added to the mixture to initiate the reaction. The hydrolysis of the substrate was followed by monitoring the increase in absorbance due to the liberation of the product p-nitroaniline at 405 nm at 30-s intervals for 60 min using a plate reader. The rate of hydrolysis was determined using a molar absorptivity of " mM ¼ 10:5 at 405 nm for p-nitroaniline. One unit was defined as the amount of the enzyme that cleaves 0.1 mmol of the substrate in 1 min at 22 C. Under the conditions used, no color was developed in any samples where the inhibitor was included.
Determination of alkaline phosphatase (ALP) activity. The cells that remained attached after 24 h of incubation with SFM, SFM containing 300 nM rGzmA, or SFM containing 100 mM RA were washed 3 times with PBS, exposed to 50 ml of 1% Triton X-100 solution, and incubated for 30 min on ice. The Triton extracts were harvested by pipetting, and insoluble debris was removed by centrifugation at 10,000 g for 10 min at 4 C. The resulting supernatants were stored at À20 C until use. ALP assay using p-NPP was carried out in a buffer (50 mM glycine, pH 10.5, containing 2 mM MgSO 4 , 2.5 mM ZnSO 4 ) at 25 C in 96-well plates. The reaction was initiated by the addition of 10 ml of Triton extracts to 90 ml of assay buffer containing 5.5 mM p-NPP. Hydrolysis of p-NPP was followed by monitoring the increase in absorbance at 405 nm due to the liberation of the product p-nitrophenol for 60 min at 30-s intervals using a plate reader.
Attachment of IEC-6 cells with ECM components.
Cell culture with ECM components was performed as follows: Cells grown with DMEM containing serum were washed twice with PBS and detached by repeated pipetting with PBS containing 1 mM EDTA. Cells were precipitated by centrifugation at 5,000 g for 2 s at 22 C, and the cell pellets were resuspended in SFM. Centrifugation and suspension of cells were repeated once to remove EDTA. The final cell pellet was suspended in SFM in which collagen IV, fibronectin, or laminin was included at a final concentration of 50 mg/ml. Cells in each suspension were seeded into 48-well plates at a density of 1 Â 10 4 cells/well. Two h after plating, the cells were washed twice with SFM and then exposed to SFM with and without 300 nM rGzmA, incubated for an additional 24 h, and analyzed by light microscopy and cell detachment assay, as described above.
Cell attachment to culture supports pre-treated with serum. Wells of a 48-well microplate were incubated with 100 ml of DMEM containing 5% serum and 4 mg/l insulin for 2 h at 37 C. After incubation, the wells were washed twice with SFM, exposed to 50 ml of SFM with and without 300 nM rGzmA, and incubated for an additional 24 h. After removal of SFM (or SFM containing rGzmA), each well was washed three times with SFM. Then IEC-6 cells that had been detached using EDTA and resuspended in SFM (see above) were added to the wells.
Statistical analysis. Differences in values were determined by the two-tailed unpaired t-test or the alternate Welch test using Instat statistical software (GraphPad, San Diego, CA). A P-value of less than 0.05 was considered to be statistically significant.
Results

rGzmA caused morphological changes and increased detachment of IEC-6 cells
Light microscopic observation and detachment assay were performed to examine the effects of rGzmA on adhesion to the culture supports of IEC-6 cells. IEC-6 cells were grown to 90% confluence in the presence of serum (Fig. 1a) . The cells cultured with SFM alone continued to grow, and at 48 h exhibited the typical appearance of monolayer epithelium with a polygonal structure (Fig. 1b) . During the 48-h incubation, a small number of the cells rounded up and detached, mostly as single cells (Figs. 1b and 2) . Figure 1c -f shows time-dependent changes in morphology of the IEC-6 cells incubated with SFM containing 300 nM rGzmA. By 12 h, several holes developed, around which flattened and elongated cells were present (Fig. 1c, see asterisks) . At this point in the incubation, no cell detachment was evident ( Fig. 2A) . At 24 h, cell elongation continued, along with the formation of bands around which cell aggregates twisted, especially at the junctions of the bands (Fig. 1d and e) . Consequently, the holes became large and a reticulated pattern emerged (Fig. 1d) . In some cases, no such reticulated pattern was observed, but cell elongation and the formation of cell aggregates were always evident (Fig. 1e) . At this point in the incubation, the number of detached cells apparently increased as compared to that of the cells incubated with SFM alone (Fig. 2A) . At 48 h, the reticulated pattern was no longer seen; elongated cells had disappeared and many cells had coalesced into islands composed of more than 100 cell aggregates (Fig. 1f) . The number of detached cells had also further increased, and in some cases very few cells remained attached ( Fig. 2A and B) . During incubation with rGzmA, the cells were detached in several aggregates, suggesting that rGzmA can cause a reduction in cellsubstratum adhesion, does so less than it reduces cellcell adhesion. Similar time-dependent morphological changes (data not shown) and detachment (Fig. 2B) were found when the cells were incubated with 150 nM rGzmA. When incubated with 75 nM rGzmA for 48 h, no apparent deformation (data not shown) or detachment (Fig. 2B) detachment of the cell line for up to 48 h. It is noteworthy that confluent IEC-6 cells were detached by 100 nM trypsin but not by 300 nM rGzmA (for up to 120 h). This suggests that the components of tight junction are resistant to rGzmA.
The rGzmA-induced morphological changes and increased detachment were abolished by concomitant incubation with PSTI or sulfated glycosaminoglycans PSTI is a potent trypsin inhibitor mainly found in pancreatic juice. 19) This inhibitor is also known to occur in the blood. 20) We have found that of proteins in the Triton extract of the small-intestinal mucosae of rats, PSTI can bind only to GzmA, and that the hydrolysis of BLT (a synthetic substrate commonly used in the determination of GzmA activity) catalyzed by rGzmA was inhibited by PSTI. 8, 18) This indicates that GzmA can be inhibited by PSTI occurring in the blood. Preliminary experiments revealed that 60 mM PSTI was required for complete inhibition of the hydrolysis of BLT catalyzed by 300 nM rGzmA in SFM, and that 60 mM rPSTI alone had no effect on the morphology (data not shown) or detachment (Fig. 3A) of IEC-6 cells. Neither morphological changes (data not shown) nor increased detachment (Fig. 3A) occurred when cells were incubated with 300 nM rGzmA and 60 mM rPSTI. This indicates that the proteolytic activity of rGzmA is required for the effects on IEC-6 cells, and that the morphological changes and detachment are due to rGzmA and not to any yeastderived contaminants.
We have found that sulfated glycosaminoglycans such as heparin enhance the rGzmA-catalyzed hydrolysis of BLT. 17) In the present study, we examined to determine whether sulfated glycosaminoglycans would facilitate the rGzmA-induced morphological changes and detachment of IEC-6. Unexpectedly, heparin, when included at a concentration of 1 mg/ml, significantly suppressed rGzmA-induced morphological changes (data not shown) and cell detachment (Fig. 3B) . Neither morphological changes (data not shown) nor increased detachment (Fig. 3B ) occurred when heparin was included at a concentration of 10 mg/ml. Chondroitin sulfate A, another sulfated glycosaminoglycan, also abolished the effects of rGzmA, although less efficiently than heparin (Fig. 3B) .
rGzmA-induced detachment was not accompanied by apoptosis in IEC-6 cells
Detachment of cells from culture supports is known to induce apoptosis (also known as anoikis) in a variety of cell types including IECs. 3, 4) Hence, it is important to ask whether the rGzmA-induced detachment of IEC-6 cells is accompanied by anoikis. STS (0.1-1 mM) is known to induce apoptosis in IEC-6 cells. 15) In order to address the validity of assays in evaluating apoptosis, IEC-6 cells were also treated with STS alone. IEC-6 cells were detached mostly as single cells by 0.1 mM STS treatment (data not shown). The cell aggregates detached by rGzmA treatment but not the cells detached by STS treatment were re-attached and propagated in new plates. TUNEL staining of cells that remained attached and caspase-3 activity in the attached and detached cells also indicated that rGzmA did not induce anoikis in IEC-6 cells ( Fig. 4A and B) .
rGzmA-induced morphological changes were not accompanied by increased activity of ALP It has been reported that elongation and formation of multilayered aggregates with a reticulated pattern in IEC-6 cells are accompanied by the induction of differentiation markers of enterocytes such as ALP. [12] [13] [14] We examined to determine whether the rGzmA-induced morphological changes in IEC-6 cells are associated with functional differentiation, by determining ALP activity in the cells. RA has been found to increase ALP activity in IEC-6 cells over a concentration range of 0.01-1 mM. 21) In order to address the increase in ALP activity in IEC-6 cells under the present experimental A, Effects of rPSTI. IEC-6 cells were incubated for 48 h with SFM (none), SFM containing 60 mM rPSTI (PSTI), SFM containing 300 nM rGzmA (GzmA), or SFM containing 60 mM rPSTI and 300 nM rGzmA (GzmA þ PSTI). Data are expressed as means AE SD from 3-4 independent wells. Ã P < 0:05 versus none (alternate Welch test). B, Effects of sulfated glycosaminoglycans on rGzmAinduced detachment of IEC-6 cells. IEC-6 cells were incubated for 48 h with SFM containing 300 nM rGzmA (GzmA) without and with various concentrations of sulfated glycosaminoglycans: þH1, 1 mg/ml of heparin; þH10, 10 mg/ml of heparin; þC10, 10 mg/ml chondroitin sulfate A; þC100, 100 mg/ml of chondroitin sulfate A; þC1000, 1000 mg/ml of chondroitin sulfate A. Data are expressed as means AE SD from three independent wells. Ã P < 0:05 versus GzmA in (alternate Welch test).
conditions and the validity of the assay for ALP activity, a control experiment in which the cells were stimulated with RA was also performed. Under the present experimental conditions no significant increase in ALP activity was found in the cells treated with SFM containing 1 mM RA as compared to those treated with SFM alone (data not shown). On the other hand, the cells treated with SFM containing 100 mM RA showed a significant increase in activity (Fig. 5) . No significant increase in ALP activity was observed in the cells treated with rGzmA (Fig. 5) .
The morphological changes and increased detachment of IEC-6 induced by rGzmA were due to cleavage of ECM components
In the experiments described above, IEC-6 cells were plated in DMEM containing serum that included a complex mixture of ECM components, such as fibronectin. We examined to examine whether the deformation and detachment were due to cleavage of ECM components. Upon rGzmA treatment, elongation and formation of multilayered aggregates were evident in the cells plated with collagen IV and fibronectin, but not in those plated with laminin (Fig. 6A ). In addition, rGzmA caused significantly increased detachment of the cells plated with collagen IV and fibronectin but not of those plated with laminin (Fig. 6B) . These results suggest that the rGzmA-induced morphological changes and detachment in cells attached with serum were mainly due to cleavage of ECM components, including collagen IV and fibronectin. This conclusion is further supported by the fact that IEC-6 cells attached to the dishes preincubated with serum but not to those pre-incubated with serum and then exposed to rGzmA (data not shown).
Discussion
In the present study, we found that rGzmA causes morphological changes and detachment of IEC-6 cells. However, there existed a threshold (75-150 nM) for causation of these effects (see Fig. 2B ). Previous studies IEC-6 cells (90% confluence) were incubated for 24 h at 37 C with SFM (none), SFM containing 300 nM rGzmA (GzmA), or SFM containing 100 mM RA (RA). The ALP activity in cells incubated with SFM alone was taken as 100%. Data are expressed as means AE SD from six independent wells. Ã P < 0:01 versus none (two-tailed, unpaired t-test).
have found that in the granules of activated cytotoxic lymphocytes, GzmA is present at a concentration of about 100 mM, 6) and that GzmA-positive IELs are generally in contact with the basement membrane. 7, 8) We suggest that the function of GzmA in the small intestine is highly restricted to regions where degranulation of GzmA-positive IELs occurs. We also found that rGzmA causes neither morphological changes nor detachment of confluent IEC-6 cells. Together with the formation of cell aggregates (Fig. 1f) , we suggest that GzmA does not affect cell-cell adhesion considerably.
Under rGzmA treatment, morphological changes and detachment were evident in IEC-6 cells plated with collagen IV and fibronectin, but not in those plated with laminin (Fig. 6 ). This strongly suggests that the deformation and detachment of cells plated in the presence of serum are accounted for by cleavage of collagen IV and fibronectin by rGzmA. The lack of morphological changes and detachment in cells attached with laminin is in good agreement with a previous finding that laminin is resistant to GzmA. 22) Vettel et al. reported that GzmA can bind to heparan sulfate proteoglycans in the basement membranes prepared from kidney, a bond that is completely inhibited in the presence of sulfated glycosaminoglycans such as fucoidan. 23) In the present study, we found that rGzmA-induced deformation and detachment of IEC-6 cells were abolished in the presence of heparin or chondroitin sulfate A (Fig. 3B) . Our interpretation is that binding between rGzmA and certain heparan sulfate proteoglycans brings the enzyme into the close vicinity of other ECM constituents for cleavage and that soluble sulfated glycosaminoglycans interrupt binding, thereby inhibiting the deformation and detachment of IEC-6 cells caused by rGzmA. Also we cannot exclude the possibility that soluble sulfated glycosaminoglycans bind to ECM proteins and protect them from cleavage by rGzmA.
It is important to ask whether the rGzmA-induced reduction of adhesion of IEC-6 cells is accompanied by anoikis. Granzyme B (GzmB) is another serine protease (Asp-ase) that is found in activated cytotoxic lymphocytes and participates in the induction of apoptosis in growing tumor and virus-infected cells. 5) Recently, GzmB has been found to induce detachment and anoikis of primary human umbilical vein endothelial cells and breast adenocarcinoma cell line MCF-7, through cleavage of fibronectin, vitronectin, and laminin. 24) In the present study, however, we found no evidence that detachment of IEC-6 cells by rGzmA was accompanied by anoikis. This may be due to the preservation of cellcell contacts even after cellular detachment by rGzmA (see Fig. 1f ). We suggest that other stimuli capable of A, Light microscopic observation. IEC-6 cells were plated with SFM containing collagen IV, fibronectin, or laminin. After allowing for attachment, the cells were washed with SFM, exposed to SFM alone or SFM containing 300 nM rGzmA, incubated for 24 h, and then photographed. Only photographs of IEC-6 cells exposed to rGzmA are presented. Each photograph is representative of three independent wells. Bar ¼ 50 mm. B, Cell detachment assay. IEC-6 cells were plated with SFM containing collagen IV, fibronectin, or laminin. After attachment, the cells were washed with SFM, exposed to SFM alone [GzmA (À)] or SFM containing 300 nM rGzmA [GzmA (þ)], and incubated for 24 h. After light microscopic observation, detachment of cells was assessed as described in ''Materials and Methods.'' Data are expressed as means AE SD from three wells.
Ã P < 0:05 versus respective GzmA (À) (alternate Welch test).
reducing cell-cell adhesion are required for the induction of anoikis. It has been reported that IEC-6 cells are extraordinarily elongated or form multilayered aggregates with a reticulated pattern when grown on a 3-D gel of reconstituted basement membrane prepared from the Engelbreth-Holm-Swarm sarcoma, 12, 13) or cultured post confluence. 14) More importantly, the morphological changes were accompanied by the expression of differentiation marker enzymes for IECs such as ALP. 12, 14) Surprisingly, the morphological appearance of IEC-6 cells incubated with rGzmA for 24 h (see Fig. 1d and e) was very similar to those cultured under other conditions. [12] [13] [14] Upon rGzmA treatment, however, no increase in ALP activity was evident at this point in incubation (Fig. 5) . Hence it is thought that the morphological changes induced by rGzmA are a consequence of a reduction in cell-substratum adhesion, and that they do not reflect differentiation of IEC-6 cells.
In summary, we found that rGzmA causes deformation and detachment of IEC-6 cells. This is probably due to cleavage of ECM components. These findings suggest that GzmA in the small intestine reduces adhesion between IECs and the basement membranes, but it appears unlikely that GzmA is the only protease responsible for reduction at this site. For instance, trypsin, abundantly present in the small-intestinal lumen, also plays a role in the detachment of IECs. Nevertheless, the present results, together with evidence of the abundant presence of GzmA where IECs are shed into the lumen, 7, 8) suggest that GzmA makes a considerable contribution to the shedding of IECs.
